Histone Acetyltransferase Activators and Uses Thereof
The invention provides for a method for screening compounds that bind to and modulate a histone acetyltransferase protein. The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a HAT-activating compound to a subject.
Patents:WO 2,011,072,243
Inventor(s):
FENG YEN [US]; FA MAURO [US]; ARANCIO OTTAVIO [US]; DENG SHIXIAN [US]; LANDRY DONALD W [US]; FRANCIS YITSHAK [US]
Type of Offer:
Licensing
« More Biotech Patents